CLEVELAND (March 3, 2008) — Ulmer & Berne LLP, which is celebrating its 100th Anniversary this year, announced the addition of Linda S. Glassman and Camille D. Kuri. Both Ms. Glassman and Ms. Kuri have joined the Firm’s Product Liability Group and its Asbestos Subgroup.
Product liability, toxic tort, asbestos and silica comprise Ms. Glassman’s practice concentrations. She holds extensive experience in defending asbestos personal injury claims in depositions on behalf of product manufacturers, distributors, suppliers and professional service providers. She is also experienced in defending silica personal injury claims in depositions on behalf of product manufacturers and suppliers. Prior to joining Ulmer & Berne, Ms. Glassman was a solo practitioner and before that worked as an attorney for Allmerica Financial in Beachwood, Ohio. She also previously worked for Ulmer & Berne.
Ms. Kuri’s practice focuses on asbestos and product liability. She has significant experience in complex asbestos litigation in the State of Ohio on behalf of manufacturers, distributors, and service providers. Ms. Kuri also has expertise in defending silica personal injury claims in depositions on behalf of product manufacturers and suppliers. Prior to joining Ulmer & Berne, Ms. Kuri was as a solo practitioner and before that was an attorney with Keller & Curtin Co. L.P.A.
Ulmer & Berne LLP, established in 1908, is one of Ohio’s largest law firms. In a survey of Fortune 500 companies by Corporate Counsel magazine, Ulmer & Berne has been chosen as a Go-To Law Firm® for both 2007 and 2008. Less than one-half of one percent of all the law firms in the US and abroad received this distinction. Also, in 2007, the Firm was recognized in The BTI Consulting Group’s survey of corporate counsel as one of only 85 firms nationally that “delivers the best value for the dollar.”
A full-service Firm with 180 attorneys in Cleveland, Columbus, Cincinnati and Chicago, Ulmer & Berne represents publicly traded and privately held companies, financial institutions, pharmaceutical companies, family businesses, international joint ventures and affiliations, investor groups, start-ups and emerging businesses, public bodies and nonprofit organizations. For more information, visit www.ulmer.com.